Calculating The Intrinsic Value Of Edwards Lifesciences Corporation (NYSE:EW)
In this article we are going to estimate the intrinsic value of Edwards Lifesciences Corporation ( NYSE:EW) by taking the forecast future cash flows of the company and discounting them back to today's value. We will use the Discounted Cash Flow (DCF) model on this occasion. It may sound complicated, but actually it is quite simple!
Edwards Lifesciences Corp. closed 24.63% below its 52-week high of $96.12, which the company reached on March 28th.
In the latest quarter, 11 analysts provided ratings for Edwards Lifesciences EW, showcasing a mix of bullish and bearish ...
Favorable hospitalization trend, strong adoption of transcatheter heart valves and improved procedural volume are expected to have aided EW in the fourth quarter.
Shares of Edwards Lifesciences Corp. advanced 4.86% to $72.56 Tuesday, on what proved to be an all-around great trading ...
Edwards Lifesciences shares rise as analyst upgrades stock, citing TAVR growth, margin expansion, and strategic business ...
Edwards Lifesciences Veteran Katie Szyman Named Next Masimo CEO. The Irvine-based medical device maker last week announced ...
Edwards Lifesciences Corp. engages in the patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into three areas: Transcatheter Heart ...
周四，Stifel分析师将Edwards Lifesciences股票评级从持有上调至买入，理由是经导管主动脉瓣置换（TAVR）市场的潜在增长加速。该公司还将Edwards Lifesciences的目标价从$75.00上调至$90.00。根据 InvestingPro 数据，Edwards Lifesciences目前市值为$41.95 ...
Edwards Lifesciences (EW) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback